Email this article Translation cellular immunotherapy of idiopathic and immunosuppressive Kaposi's sarcoma
- Authors: Kartashova M.G1, Kildyushevsky A.V1, Molochkov A.V1, Fedulkina V.A1
-
Affiliations:
- M.F. Vladimirsky Moscow Regional Research and Clinical Institute
- Issue: Vol 16, No 3 (2013)
- Pages: 13-18
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/36758
- DOI: https://doi.org/10.17816/dv36758
- ID: 36758
Cite item
Full Text
Abstract
Translation cellular immunotherapy with ammifurine photosensitizer and UV irradiation (spectrum A) of cellular mononuclear suspension (λ = 320-340 nm, 90 min), followed by its reinfusion, were carried out in 20 patients with Kaposi’s sarcoma (15 with the idiotypical and 5 with immunosuppressive type) aged 32-75 years. Evaluation of the immune status of patients, including phenotyping, was carried out before and after therapy and demonstrated the treatment efficiency, shown by the time course of the clinical picture and periods of disease remission. The treatment efficiency is explained by induction of antitumor immunological surveillance. Relevant publications (8 references) are discussed.
Full Text
##article.viewOnOriginalSite##About the authors
M. G Kartashova
M.F. Vladimirsky Moscow Regional Research and Clinical Institute
Email: maxa.ka@mail.ru
кандидат мед. наук, научный сотрудник
A. V Kildyushevsky
M.F. Vladimirsky Moscow Regional Research and Clinical Instituteдоктор мед. наук, профессор, ведущий научный сотрудник
A. V Molochkov
M.F. Vladimirsky Moscow Regional Research and Clinical Instituteдоктор мед. наук, профессор
V. A Fedulkina
M.F. Vladimirsky Moscow Regional Research and Clinical Institute
References
- Молочков А.В., Казанцева И.А., Гурцевич В. Э. Саркома Капоши. М.: БИНОМ; 2000.
- Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., et al. Primary characterization of a herpesvirus agent associated with Kaposi’s sarcoma. J. Virol. 1996; 70(1): 549-58.
- Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D.,, Ganem D. Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 1996; 2(3): 342-6.
- Luger T.A., Schwarz T., Krutmann J., Kock A., Urbanski A., Kirnbauer R. Cytokinesand theskin. Curr. Probl. Dermatol. 1990; 19: 35-49.
- Кильдюшевский А.В., Молочков В А., Ольшанский А.Я., Молочков А.В., Фомин А.М., Гордиевская М.С. и др. Способ лечения Т-клеточных лимфом и саркомы Капоши. Патент № 2401671 от 20.10.2010. Изобретения и полезные модели. 2010; 29.
- Timmerman J.M., Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 1999; 50: 507-29.
- Aichele P., Brduscha-Riem K., Zinkernagel R.M., Hengartner H., Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 1995; 182(1): 261-6.
- Marincola F.M., Jaffee E.M., Hicklin D.J., Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 2000; 74: 181-273.
